Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 56.66
-0.95 (-1.65%)
Mar 9, 2026, 4:00 PM EDT
Bide Pharmatech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | - | 1,105 | 1,274 | 1,506 | 193.46 | Upgrade
|
| Trading Asset Securities | - | 75.52 | 0.12 | 3.97 | - | Upgrade
|
| Cash & Short-Term Investments | 1,149 | 1,181 | 1,274 | 1,510 | 193.46 | Upgrade
|
| Cash Growth | -2.68% | -7.33% | -15.61% | 680.49% | 43.70% | Upgrade
|
| Accounts Receivable | - | 227.37 | 237.35 | 177.37 | 124.68 | Upgrade
|
| Other Receivables | - | 15.39 | 10.66 | 16.79 | 9.89 | Upgrade
|
| Receivables | - | 242.76 | 248.01 | 194.16 | 134.57 | Upgrade
|
| Inventory | - | 760.22 | 699.43 | 521.86 | 476.55 | Upgrade
|
| Prepaid Expenses | - | 4.19 | 5.61 | 2.47 | 0.04 | Upgrade
|
| Other Current Assets | - | 20.7 | 33.92 | 16.19 | 13.1 | Upgrade
|
| Total Current Assets | - | 2,209 | 2,261 | 2,245 | 817.71 | Upgrade
|
| Property, Plant & Equipment | - | 166.88 | 97.32 | 75.45 | 60.04 | Upgrade
|
| Other Intangible Assets | - | 3.95 | 0.6 | 0.21 | 0.44 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 14.74 | 18.36 | 3.88 | 2.97 | Upgrade
|
| Long-Term Deferred Charges | - | 23.74 | 37.58 | 16.81 | 22.13 | Upgrade
|
| Other Long-Term Assets | - | - | - | 18.25 | 2.84 | Upgrade
|
| Total Assets | - | 2,418 | 2,415 | 2,359 | 906.13 | Upgrade
|
| Accounts Payable | - | 216.32 | 179.57 | 167.37 | 206.07 | Upgrade
|
| Accrued Expenses | - | 31.38 | 36.26 | 30.1 | 18.57 | Upgrade
|
| Short-Term Debt | - | 30.18 | 0.23 | 9.61 | 0.07 | Upgrade
|
| Current Portion of Leases | - | 14.06 | 15.88 | - | - | Upgrade
|
| Current Income Taxes Payable | - | 12.85 | 6.49 | 6.22 | 8.39 | Upgrade
|
| Current Unearned Revenue | - | 36.69 | 29.07 | 20.52 | 14.68 | Upgrade
|
| Other Current Liabilities | - | 4.28 | 7.47 | 15.25 | 1.78 | Upgrade
|
| Total Current Liabilities | - | 345.76 | 274.97 | 249.07 | 249.56 | Upgrade
|
| Long-Term Leases | - | 37.95 | 41.19 | 31.21 | 27.71 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 7.2 | 8.06 | 2.77 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.27 | - | - | Upgrade
|
| Total Liabilities | - | 390.91 | 325.49 | 283.05 | 277.27 | Upgrade
|
| Common Stock | - | 90.88 | 90.88 | 64.92 | 48.69 | Upgrade
|
| Additional Paid-In Capital | - | 1,755 | 1,754 | 1,776 | 483.24 | Upgrade
|
| Retained Earnings | - | 289.63 | 252.08 | 242.48 | 96.51 | Upgrade
|
| Treasury Stock | - | -99.99 | - | - | - | Upgrade
|
| Comprehensive Income & Other | - | -8.6 | -6.96 | -7.25 | 0.43 | Upgrade
|
| Shareholders' Equity | 2,002 | 2,027 | 2,090 | 2,076 | 628.86 | Upgrade
|
| Total Liabilities & Equity | - | 2,418 | 2,415 | 2,359 | 906.13 | Upgrade
|
| Total Debt | 236.14 | 82.2 | 57.3 | 40.82 | 27.78 | Upgrade
|
| Net Cash (Debt) | 913.03 | 1,099 | 1,217 | 1,469 | 165.68 | Upgrade
|
| Net Cash Growth | -16.90% | -9.72% | -17.17% | 786.71% | 40.92% | Upgrade
|
| Net Cash Per Share | 10.50 | 12.35 | 13.44 | 19.93 | 2.47 | Upgrade
|
| Filing Date Shares Outstanding | 85.7 | 88.33 | 90.88 | 90.88 | 68.16 | Upgrade
|
| Total Common Shares Outstanding | 86.15 | 88.33 | 90.88 | 90.88 | 68.16 | Upgrade
|
| Working Capital | - | 1,863 | 1,986 | 1,996 | 568.15 | Upgrade
|
| Book Value Per Share | 23.24 | 22.95 | 22.99 | 22.84 | 9.23 | Upgrade
|
| Tangible Book Value | 1,999 | 2,023 | 2,089 | 2,076 | 628.42 | Upgrade
|
| Tangible Book Value Per Share | 23.20 | 22.91 | 22.98 | 22.84 | 9.22 | Upgrade
|
| Buildings | - | 85.07 | 16.58 | 16.58 | 16.58 | Upgrade
|
| Machinery | - | 45.93 | 47.23 | 35.62 | 21.9 | Upgrade
|
| Construction In Progress | - | 15.41 | - | 5.1 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.